AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
66.11
-0.48 (-0.72%)
At close: Apr 28, 2026, 4:00 PM EDT
66.11
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
AnaptysBio Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for AnaptysBio stock have an average target of 71.67, with a low estimate of 20 and a high estimate of 100. The average target predicts an increase of 8.41% from the current stock price of 66.11.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AnaptysBio stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Buy | 6 | 6 | 6 | 6 | 5 | 6 |
| Hold | 3 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 11 | 12 | 12 | 11 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Maintains $66 → $85 | Buy | Maintains | $66 → $85 | +28.57% | Apr 28, 2026 |
| Barclays | Barclays | Buy Maintains $79 → $63 | Buy | Maintains | $79 → $63 | -4.70% | Apr 22, 2026 |
| UBS | UBS | Strong Buy Maintains $90 → $60 | Strong Buy | Maintains | $90 → $60 | -9.24% | Apr 21, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $67 → $95 | Buy | Maintains | $67 → $95 | +43.70% | Mar 31, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $66 | Strong Buy | Reiterates | $66 | -0.17% | Mar 30, 2026 |
Financial Forecast
Revenue This Year
138.30M
from 234.60M
Decreased by -41.05%
Revenue Next Year
210.41M
from 138.30M
Increased by 52.14%
EPS This Year
-4.11
from -0.46
EPS Next Year
-4.33
from -4.11
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 158.6M | 247.8M | ||||||
| Avg | 138.3M | 210.4M | ||||||
| Low | 87.3M | 172.9M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -32.4% | 79.2% | ||||||
| Avg | -41.0% | 52.1% | ||||||
| Low | -62.8% | 25.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -2.15 | 0.09 | ||||||
| Avg | -4.11 | -4.33 | ||||||
| Low | -6.52 | -8.38 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.